Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

NCT04620473 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No approval from ethical committee

Conditions

Neoadjuvant Treatment
Rectal Cancer
Anlotinib

Interventions

DRUG: Anlotinib+Capeox
DRUG: Capeox

Sponsor

Shanghai Minimally Invasive Surgery Center